Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving miR-210 and hypoxia-inducible factor 1

The use of mesenchymal stem cells (MSCs) has emerged as a potential new treatment for myocardial infarction. However, the poor viability of MSCs after transplantation critically limits the efficacy of this new strategy. The expression of microRNA-210 (miR-210) is induced by hypoxia and is important...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Woochul, Lee, Chang Youn, Park, Jun-Hee, Park, Moon-Seo, Maeng, Lee-So, Yoon, Chee Soon, Lee, Min Young, Hwang, Ki-Chul, Chung, Yong-An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Veterinary Science 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615234/
https://www.ncbi.nlm.nih.gov/pubmed/23388440
http://dx.doi.org/10.4142/jvs.2013.14.1.69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615234/
https://www.ncbi.nlm.nih.gov/pubmed/23388440
http://dx.doi.org/10.4142/jvs.2013.14.1.69

Ejemplares similares